E1A transformed normal human prostate epithelial cells contain a 16q deletion

Cancer Genetics and Cytogenetics

Volumn 103, Issue 2, 1998, Pages 155-163

  Chin, Robert K ^a,b   Hawkins, Anita L ^a,b   Isaacs, William B ^b   Griffin, Constance A ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Oncology ^*  (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL TRANSFORMATION; CHROMOSOME 16Q; CYTOGENETICS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KARYOTYPE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; STRAIN DIFFERENCE; TUMOR SUPPRESSOR GENE;

ADENOVIRUS E1A PROTEINS; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 16; EPITHELIAL CELLS; HUMANS; KARYOTYPING; MALE; MICE; MICE, NUDE; MIDDLE AGED; PROSTATE;

EID: 0032104108     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00407-X     Document Type: Article

References (46)

1. Parker SL, Tong T, Bolden S, Wingo PA (1996): Cancer statistics, 1996. Cancer J Clin 46:5-27.
2. Lee WH, Morton RA, Epstein JI, Brooks JD, Campell PA, Bova GS, Hsieh WS, Isaacs WB, and Nelson WG (1994): Methylation-inactivation of the gstp1 gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci 91:11733-11737.
3. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH (1990): Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rb gene. Science 247:712-715.
4. Bookstein R, Rio P, Madreperla S, Hong F, Allred C, Grizzle WE, Lee WH (1990): Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87:7762-7767.
5. Brooks JD, Bova GS, Isaacs WB (1995): Allelic loss of the retinoblastoma gene in prostate cancer. Prostate 26(1):35-39.
6. Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J (1992): Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84:883-887.
7. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC (1993): p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 53:3369-3373.
8. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, van Eschenbach AC, Conti CJ (1993): p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657-1669.
9. Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z, Cordon-Cardo C (1994): Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol 151:1276-1280.
10. Dinjens WN, van der Weiden MM, Schroeder FH, Bosman FT, Trapman J (1994): Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int J Cancer 56:630-633.
11. Voeller HJ, Sugars LY, Pretlow T, Gelmann EP (1994): p53 oncogene mutations in human prostate cancer specimens. J Urol 151:492-495.
12. Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumer-lock PH (1994): p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst 86:926-933.
13. Umbas R, Schalken J, Aalders T, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB (1992): Expression of the cellular adhesion molecule is reduced or absent in high-grade prostate cancer. Cancer Res 52:5104-5109.
14. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB (1995): E-cadherin is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Research 55:5195-5199.
15. Van Den Berg C, Guan XY, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein J, Sarosdy M, Meltzer P, Trent J (1995): DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res 1:11-18.
16. Bergerheim USR, Kunimi K, Collins VP and Ekman P (1991): Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220.
17. Issacs WB, Bova RA, Morton RA, Bussemakers MI, Brooks JD, Ewing CM (1994): Molecular biology of prostate cancer. Semin Oncol 21:514-521.
18. Kunimi K, Bergerheim USR, Larrson IL, Ekman P, Collins VP (1991): Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536.
19. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB (1990): Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8761-8855.
20. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP (1994): Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145:624-630.
21. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB (1994): Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clincially localized prostate carcinoma. J Urol 152:1157-1162.
22. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB (1994): Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 54:3574-3579.
23. Visakorpi T, Kallioniemi AH, Syvanen A, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
24. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH (1996): Genetic alterations in untreated prostate cancer metastases and androgen independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
25. Isaacs WB (1995): Molecular genetics of prostate cancer. In: Genetics and Cancer: A Second Look. BA Ponder, WK Cavenee, E Solomon, eds. Cold Spring Harbor Laboratory Press, Planview, New York, pp. 357-380.
26. Cone RD, Grodzicker T, Jaramillo M (1988): A retrovirus expressing the 12S adenoviral E1a gene product can immortalize epithelial cells from a broad range of rat tissues. Mol Cell Biol 8:1036-1044.
27. Perlman EJ, Epstein JI, Long PP, Pizov G, Griffin CA (1993): Cytogenetic and ploidy analysis of prostatic adenocarcinoma. Modern Pathol 6:348-352.
28. ISCN (1995): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
29. Guan XY, Trent JM, Metzler PS (1993): Generation of band-specific painting probes from a single microdissected chromosome. Hum Mol Genet 2:1117-1121.
30. Meltzer PS, Guan XY, Burgess A, Trent JM (1992): Rapid generation of region specific probes by chromosome microdissection and their application. Nature Genet 1:24-28.
31. Atkin NB, Baker MC (1985): Chromosome study of five cancers of the prostate. Hum Genet 70:359-364.
32. Lundgren R, Kristoffersson U, Heim S, Mandahl N, Mitelman F (1988): Multiple structural chromosome rearrangements including del(7p) and del(10q) in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35:103-108.
33. Cher ML, Takashi I, Weidner N, Carroll PR, Jensen RH (1995): Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254.
34. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffioti U, Harris CG (1989): Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40. Cancer Res 49:3050-3056.
35. Cussenot O, Berthon PH, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac P, Le Duc A, Calvo I (1991): Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urology 143:881-886.
36. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL (1994): Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58:721-729.
37. Weijerman PC, Konig JJ, Wong ST, Niesters HG, Peehl DM (1994): Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res 54:5579-5583.
38. Degeorges A, Hoffschir F, Cussenot O, Gauville C, Le Duc A, Dutrillaux B, Calvo F (1995): Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. Int J Cancer 62:724-731.
39. Tribukait B (1994): Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother 1:211-218.
40. Bright RK, Vocke CD, Emmert-Buck MR, Duray PH, Solomon D, Fetsch P, Rhim JS, Linehan WM, Topalian SL (1997): Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 57:995-1002.
41. Hoffschir F, Ricoul M, Dutrillaux B (1988): SV40-transformed human fibroblasts exhibit a characteristic chromosomal pattern. Cytogenet Cell Genet 49:264-268.
42. Ray FA, Kraemer PM (1992): Frequent deletions in nine newly immortal human cell lines. Cancer Genet Cytogenet 59:39-44.
43. Clenton-Jansen A, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisee CJ (1994): At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosom Cancer 9:101-107.
44. Sato T, Tanigami A, Kazuhiro Y, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y (1990): Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184-7189.
45. Tsuda H, Zhang W, Shimosato Y, Yokoda J, Terada M, Sugimura T, Piyamura T, Hirohashi S (1990): Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794.
46. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dun RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE (1992): A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094-3098.